Pune-based Mylab Discovery Solutions has scaled up its production and development of COVID-19 pathodetect testing kit with the help of strategic funding under National Biopharma Mission of Department of Biotechnology (DBT)-Biotechnology Industry Research Assistance Council (BIRAC).
Daily Current Affairs Quiz 2020
Key-Points
Currently, Mylab has a manufacturing capacity of 2,00,000 RT-PCR and 50,000 RNA tests. Mylab has obtained CDSCO/India-FDA and ICMR approval to manufacture for NAT, HIV, HBV, HCV, and for detection of novel coronavirus 2019-n COV/SARS-COV-2.
The company has recently launched a Molecular laboratory machine Compact XL that can manufacture various reagents as well as perform many molecular tests in a single machine unit.
The machine will help India in setting up the Molecular Diagnostic labs in rural India as it eliminates huge infrastructure costs, Capex and Opex costs since minimal number of employees can do a large number of tests.
Department of Biotechnology
The Department of Biotechnology (DBT), under the Ministry of Science & Technology, promotes and accelerates the development of biotechnology in India, including growth and application of biotechnology in the areas of agriculture, healthcare, animal sciences, environment and industry.
Biotechnology Industry Research Assistance Council
Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs
About National Biopharma Mission
The Industry-Academia Collaborative Mission of Department of Biotechnology (DBT), Govt of India for accelerating discovery research to early development for Biopharmaceuticals approved by the Cabinet for a total cost US$ 250 million and 50% co-funded by the World Bank is being implemented at Biotechnology Research Assistance Council (BIRAC).
This program is dedicated to deliver affordable products to the nation with an aim to improve the health standards of India’s population.
Vaccines, medical devices and diagnostics and biotherapeutics are few of its most important domains, besides, strengthening the clinical trial capacity and building technology transfer capabilities in the country.
